CONTEXT

Among different types of cancers, prostate cancer is a major public health issue. In the European Union, prostate cancer accounts for over 35,000 deaths every year.

There is currently no satisfying potential treatment for this type of cancer. Despite the large number of current available therapies, cancer survival is low. Therefore, there is a great need for improved prostate cancer treatment.